Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma

Both genomic and transcriptomic signatures have been developed to predict responses of metastatic melanoma to immune checkpoint blockade (ICB) therapies; however, most of these signatures are derived from pre-treatment biopsy samples. Here, we build pathway-based super signatures in pre-treatment (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Kuang, Wei, Shiyou, Wei, Zhi, Frederick, Dennie T., Miao, Benchun, Moll, Tabea, Tian, Tian, Sugarman, Eric, Gabrilovich, Dmitry I., Sullivan, Ryan J., Liu, Lunxu, Flaherty, Keith T., Boland, Genevieve M., Herlyn, Meenhard, Zhang, Gao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519947/
https://www.ncbi.nlm.nih.gov/pubmed/34654806
http://dx.doi.org/10.1038/s41467-021-26299-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519947/
https://www.ncbi.nlm.nih.gov/pubmed/34654806
http://dx.doi.org/10.1038/s41467-021-26299-4

Ejemplares similares